Copy

NEWSLETTER ISSUE - 13th October 2020  

ANNUAL CUSTOMER SURVEY

 
The Wellington SCL annual customer survey is now open until 6 November  Please follow the link to complete. 

The survey is an opportunity to confirm what we are doing well and to identify any areas for improvement. 

All completed survey replies go into the draw for one of two separately drawn prizes of a $200 medical magazine subscription of your choice , or morning tea for your practice, to go into the draw don’t forget to give your name and the name of your practice.
 

CHANGES TO THE REPORTING OF BCR-ABL1 MONITORING RESULTS

 
In April 2020, Cepheid released a new version of the Xpert BCR-ABL1 Ultra assay. While the assay chemistry remains unchanged, this upgrade results in a change to the way BCR-ABL1 results are reported. This assay version has a linear range of 0.0030% IS to 55% IS. Reporting of results will include the addition of the Molecular Response (MR).
 
In-house verification of the assay shows no difference in the transcript levels between the two assay versions, with an R2 value of 0.992, an average bias of 0.02 log % IS and a standard deviation of 0.108.
 
The table below gives an example of how different patient results are reported.

These changes have come into effect in September 2020.



Chor Ee Tan
Molecular Biology

Copyright © *2020* *Wellington SCL*, All rights reserved.

Our mailing address is:
Wellington
Level 5, CSB Block
Wellington Hospital, Riddiford Street
Wellington, Wgn 6011
New Zealand

Add us to your address book


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Wellington · Level 5, CSB Block · Wellington Hospital, Riddiford Street · Wellington, Wgn 6011 · New Zealand

Email Marketing Powered by Mailchimp